AAAAAA

   
Results: 1-8 |
Results: 8
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes
Authors: Mazzocchi, A Melani, C Rivoltini, L Castelli, C Del Vecchio, M Lombardo, C Colombo, MP Parmiani, G
Citation: A. Mazzocchi et al., Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes, CANCER IMMU, 50(4), 2001, pp. 199-211
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells
Authors: Castelli, C Ciupitu, AMT Rini, F Rivoltini, L Mazzocchi, A Kiessling, R Parmiani, G
Citation: C. Castelli et al., Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells, CANCER RES, 61(1), 2001, pp. 222-227
Gene therapy in melanoma
Authors: Parmiani, G Arienti, F Melani, C Belli, F Gallino, G Mazzocchi, A
Citation: G. Parmiani et al., Gene therapy in melanoma, METH MOL M, 61, 2001, pp. 203-222
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999)
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Santantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999), HUM GENE TH, 11(6), 2000, pp. 981-981
Type I consensus interferon (CIFN) gene transfer into human melanoma cellsup-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha
Authors: Mecchia, M Matarrese, P Malorni, W D'Agostino, G Sestili, P Santini, SM Gauzzi, MC Venditti, M Mazzocchi, A Parmiani, G Belardelli, F Ferrantini, M
Citation: M. Mecchia et al., Type I consensus interferon (CIFN) gene transfer into human melanoma cellsup-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha, GENE THER, 7(2), 2000, pp. 167-179
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Sanantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells, HUM GENE TH, 10(18), 1999, pp. 2907-2916
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens
Authors: Castelli, C Tarsini, P Mazzocchi, A Rini, F Rivoltini, L Ravagnani, F Gallino, F Belli, F Parmiani, G
Citation: C. Castelli et al., Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J IMMUNOL, 162(3), 1999, pp. 1739-1748
A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy
Authors: Rivoltini, L Squarcina, P Loftus, DJ Castelli, C Tarsini, P Mazzocchi, A Rini, F Viggiano, V Belli, F Parmiani, G
Citation: L. Rivoltini et al., A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy, CANCER RES, 59(2), 1999, pp. 301-306
Risultati: 1-8 |